pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? Lilly is now pharma's top
Description
References 1.Weir G
Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects
Neuropsychopharmacology 32, 471482
and Carey, EJ., 2024
Association of GLP-1 receptor agonists with chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes
Products to support your goals Find products* you may need along your journey, from snacks and supplements to hydration, digestive support and more
